The present invention is directed to a method of treating a subject for a disease or disorder associated with Trpv2 activity. The present invention also relates to a compound having the following structure:where substituents A and R1-R5 are as defined herein. Also disclosed is a composition and a method of increasing Trpv2 activity in a cell or tissue.
